Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues

被引:20
作者
Geist, RT
Reddy, AJ
Zhang, J
Gutmann, DH
机构
[1] WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110
关键词
D O I
10.1006/nbdi.1996.0011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tuberous sclerosis (TS) is an autosomal dominant disorder in which affected individuals manifest mental retardation, seizures, and a variety of benign and malignant tumors. The TSC2 tumor suppressor gene was recently identified by positional cloning and its protein product, tuberin, shown to represent one member of the rap GTPase activating protein (rapGAP) family. In order to determine the contribution of tuberin to the development of mental retardation and seizures in patients with TS, we examined the expression of tuberin in adult and developing nervous system tissues. Since tuberin is the second rapGAP found in the nervous system, the expression of tuberin was compared to the expression of rapGAP, rap1, and rap2. In this study, we demonstrate that tuberin is expressed at greatest levels in the spinal cord and cerebellum as opposed to rapGAP, which is not enriched in these tissues. Tuberin expression in the adult CNS is restricted to the olfactory bulb, several CNS neuronal populations, brainstem nuclei, cerebellar Purkinje cells, and motor neurons in the ventral spinal cord. In contrast, rapGAP is expressed in many different cell types in the adult CNS, but not in cerebellar Purkinje cells or motor neurons in the ventral spinal cord. However, there is significant expression of rapGAP in astrocytes. The restricted distribution of tuberin expression relative to rap1 and rapGAP suggests that tuberin may be the primary rap1 regulator in a subpopulation of CNS neurons. (C) 1996 Academic Press, Inc.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 19 条
[1]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[2]  
*EUR CHROM 16 TUB, 1993, CELL, V75, P1305
[3]  
GEIST RT, 1995, CELL GROWTH DIFFER, V6, P1477
[4]  
Gomez M.R., 1988, TUBEROUS SCLEROSIS, VSecond
[5]  
GREEN AJ, 1993, AM J HUM GENET, V53, P244
[6]   MODULATION OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT, NEUROFIBROMIN, DURING SCHWANN-CELL DIFFERENTIATION [J].
GUTMANN, DH ;
TENNEKOON, GI ;
COLE, JL ;
COLLINS, FS ;
RUTKOWSKI, JL .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 36 (02) :216-223
[7]   IDENTIFICATION OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT [J].
GUTMANN, DH ;
WOOD, DL ;
COLLINS, FS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9658-9662
[8]  
HAINES JL, 1991, AM J HUM GENET, V49, P764
[9]   SELECTIVE POTENTIATION OF NMDA-INDUCED NEURONAL INJURY FOLLOWING INDUCTION OF ASTROCYTIC INOS [J].
HEWETT, SJ ;
CSERNANSKY, CA ;
CHOI, DW .
NEURON, 1994, 13 (02) :487-494
[10]  
JANSSEN LAJ, 1991, ANN NY ACAD SCI, V615, P306